Surgery to Prevent Reflux in IPF Patients May Be Superior to Anti-Acid Medicines, Study Says

Surgery to Prevent Reflux in IPF Patients May Be Superior to Anti-Acid Medicines, Study Says

Surgery to prevent reflux in patients with interstitial pulmonary disease may slow disease progression, by stopping tiny amounts of contents in the stomach from being repeatedly aspirated into the lungs — a process thought to contribute to disease development in IPF. This was the conclusion of a review looking into gastroesophageal reflux disease —…

Just Let Me be Mad

For the people around me on a regular basis, I admit I have not been the most pleasant person this week. I have been far from myself and instead have been grumpy, irritable, quiet and mad. This is unlike me and I know it. I also hate…

Lung Therapeutics Raises $14.3 Million to Develop Treatments for Pulmonary Fibrosis, Other Diseases

Lung Therapeutics announced June 6 that it has completed a $14.3 million Series B financing round to support development of LTI-03, its lead therapy for idiopathic pulmonary fibrosis (IPF). LTI-03 has already showed promising results for other conditions including scleroderma and cardiac fibrosis. The funds will also support clinical trials, now underway in Australia and…

The Economic Impact of Lung Disease

Lung disease has a deep impact in Canada. Lung cancer remains the leading cause of death from cancer for both genders and each year more people die of lung cancer than those of prostate cancer, breast cancer, and colorectal cancer combined. MORE:…